Brussels Eye Center




ACRILISA is a new generation of intra-ocular lens used for cataract surgery. This bifocal lens is fitted with a high performance optical technique allowing good vision at 70 cm and near vision between 30 and 40 cm with an intermediate vision between 50 and 70 cm.

96 % of the patients operated for cataract surgery and implanted with ACRILISA are independent of glasses.

ACRILISA is fitted with a new UV filter to protect the retina.
TORIC ACRILISA: in 2008 TORIC ACRILISA is released for the correction of cataract surgery allowing the treatment in the same time of myopia, hyperopia, astigmatism and presbyopia.

It is one of the few models available to correct simultaneously near, far and intermediate visions with astigmatism during the same procedure.


Advantages of multi-focal intra-ocular lenses:

  • independence of glasses in 80 to 90 % of the cases,
  • good vision for far vision intermediate and near vision without correction,
  • correction with TORIC ACRILISA of astigmatism simultaneously,
  • foldable intra-ocular lens implantable with a small incision of 2.2 mm with vision recovery the day after.


  • halos by night visions are possible,
  • in few cases, far or near vision are not optimal and need glasses for better correction or secondary treatment by laser Excimer,
  • need of good lightening for near reading without glasses
  • same disadvantages of cataract surgery with any intra-ocular lens (cf. cataract).

Post-operative followings:

  • Fast visual recovery: 24h
  • No post operative pain

Complications (same as cataract surgery):

  • High intra-ocular pressure treatable by local eye drops or oral medications
  • Risk of infection: 3/1000
  • Macular oedema controlled by local treatment
  • Low risk of retinal detachment, mainly in high myopia or patients with degenerative lesions that can be checked and treated before surgery
  • Risk of secondary cataract

Link :


Multifocal and pseudo-accomodative implants